Since 1996, Evaluate has provided the life sciences industry with the data, insight and intelligence to facilitate confident decision-making on high-value investments in treatments and markets. We enable our clients to embed our proprietary and industry data into their workflows, tools and processes so they can work more effectively and efficiently.
At MMIT, we believe that patients who need life-saving treatments shouldn’t face delays because of the barriers to accessing therapies. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions.
Divisions of MMIT include AIS Health, Zitter Health Insights and RJ Health.
Panalgo provides software that streamlines healthcare data analytics by removing complex programming from the equation. Our Instant Health Data (IHD) software empowers teams to generate and share trustworthy results faster, enabling more impactful decisions. To request a demo of our IHD software, please contact us at email@example.com.
The Dedham Group is the preeminent U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry. The team applies a holistic approach linking engagement, distribution, access support, pricing/contracting, and data strategies to address the most challenging emerging issues facing its clients, making the Dedham team key influencers in the oncology and specialty therapeutics space.
We're looking for agile, growth-oriented team players who are passionate about client success and helping patients get access to the therapies they need.Work with us
Have questions about Norstella or its brands? Or do you want to know more about how to solve your market access challenges?We want to hear from you